Abbott Laboratories insider trading

Bought

$1.3M

Sold

$46.9M

none on a 10b5-1 plan

Net

−$45.5M

Insiders

6

• McCoy John A. Jr.

  Vice President And Controller

  −$3K

  Sep 02, 2026

  27 sh · $109.54

• Ford Robert B

  Chairman And CEO · Director

  −$25.3M

  Aug 25, 2026

  218,535 sh · $115.57

• Ford Robert B

  Chairman And CEO · Director

  −$20.9M

  Aug 25, 2026

  180,297 sh · $116.19

• Morrone Louis H.

  Executive Vice President

  −$642.5K

  Aug 11, 2026

  5,850 sh · $109.83

• Stratton John G

  Director

  +$173.6K

  May 07, 2026

  2,000 sh · $86.82

• Starks Daniel J

  Director

  +$926.5K

  Apr 27, 2026

  10,000 sh · $92.65

• Boudreau Philip P

  EVP And CFO

  +$201.3K

  Apr 23, 2026

  2,200 sh · $91.50

Largest purchase

+$2M of ABT by Ford Robert B (Chairman And CEO · Director) on Jan 23, 2026.

Largest sale

−$37.4M of ABT by Ford Robert B (Chairman And CEO · Director) on Feb 05, 2025.

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

SEC industry classification

Pharmaceutical Preparations

Headquarters

Abbott Park, IL

Incorporated in

IL

Listed on

NYSE

SEC Central Index Key

0000001800

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

Open-market purchase (code P)

An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.

Grants and option exercises (codes A, M)

Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.

Cluster buy

Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Are ABT insiders buying or selling?

Between Apr 23, 2026 and Sep 02, 2026, 6 Abbott Laboratories insiders made 3 open-market purchases worth $1.3M and 4 sales worth $46.9M, a net sale of $45.5M.

How much ABT stock have insiders bought and sold in the last two years?

Between Jul 01, 2024 and Jun 30, 2026, 14 Abbott Laboratories insiders made 6 open-market purchases worth $4.4M and 27 sales worth $114.6M. 3 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 6 purchases ($4.4M) and 8 sales ($1.4M). The largest purchase was Ford Robert B buying $2M on Jan 23, 2026. The largest sale was Ford Robert B selling $37.4M on Feb 05, 2025.

What was the largest recent ABT insider trade?

Ford Robert B (Chairman And CEO · Director) sold $25.3M of ABT stock on Aug 25, 2026 at about $115.57 a share.

When did an insider last buy ABT shares?

The most recent open-market purchase on file is Stratton John G (Director) buying $173.6K on May 07, 2026. The largest purchase in the period was $926.5K by Starks Daniel J.

Where does ABT insider trading data come from?

From the Form 4 filings Abbott Laboratories's officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.